CRIS Current Research Information System

DURANTE, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.513
EU - Europa 1.810
AS - Asia 1.608
AF - Africa 241
SA - Sud America 88
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.265
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.485
CN - Cina 513
SG - Singapore 494
GB - Regno Unito 443
IT - Italia 310
SE - Svezia 298
VN - Vietnam 292
DE - Germania 249
HK - Hong Kong 118
RU - Federazione Russa 101
IN - India 88
NL - Olanda 76
IE - Irlanda 72
FR - Francia 67
CI - Costa d'Avorio 61
BR - Brasile 59
CH - Svizzera 57
TG - Togo 51
NG - Nigeria 49
ZA - Sudafrica 42
EE - Estonia 33
UA - Ucraina 32
JO - Giordania 30
IR - Iran 28
FI - Finlandia 27
SC - Seychelles 27
CA - Canada 21
ID - Indonesia 15
AR - Argentina 14
BG - Bulgaria 11
BE - Belgio 10
JP - Giappone 9
IQ - Iraq 7
PL - Polonia 7
CO - Colombia 6
MX - Messico 6
AT - Austria 3
AU - Australia 3
DZ - Algeria 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
TR - Turchia 3
BD - Bangladesh 2
CL - Cile 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
GR - Grecia 2
KE - Kenya 2
MA - Marocco 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
GY - Guiana 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 6.265
Salva come PNG Salva come JPEG
Città #
Southend 406
Ashburn 336
Singapore 331
Chandler 249
Fairfield 233
Beijing 119
Hong Kong 118
Houston 117
Santa Clara 112
Woodbridge 108
Wilmington 104
Seattle 102
Ann Arbor 92
Princeton 91
Dong Ket 84
Dallas 75
Cambridge 74
Dublin 72
Abidjan 61
Bern 56
Bologna 51
Lomé 51
New York 50
Boardman 46
Nanjing 45
Pavia 45
Padova 40
Westminster 40
Ho Chi Minh City 32
Los Angeles 31
Amman 30
Abeokuta 27
Jinan 27
Medford 25
Nanchang 25
Shenyang 23
Berlin 22
Helsinki 22
Frankfurt am Main 21
Saint Petersburg 20
Munich 18
Hanoi 17
Bremen 16
Buffalo 16
Hebei 16
Milan 16
Washington 16
San Diego 15
Tianjin 15
Turin 14
Kuban 13
Redondo Beach 12
Changsha 11
Falkenstein 11
Florence 11
Sofia 11
Tehran 11
Tongling 11
Brussels 10
Guangzhou 10
Hangzhou 10
Igea Marina 10
Toronto 10
Falls Church 9
Chengdu 8
Pune 8
Rome 8
São Paulo 8
Tokyo 8
Calderara Di Reno 7
Haiphong 7
Jakarta 7
Jiaxing 7
Redwood City 7
Zhengzhou 7
Denver 6
Jacksonville 6
Johannesburg 6
Shanghai 6
Bühl 5
Haikou 5
Lauterbourg 5
Mülheim 5
Ningbo 5
Redmond 5
San Mateo 5
Turku 5
Yubileyny 5
Argelato 4
Como 4
Dearborn 4
Fremont 4
Hefei 4
Lanzhou 4
Leawood 4
Taiyuan 4
Wuhan 4
Baghdad 3
Biên Hòa 3
Brooklyn 3
Totale 4.118
Salva come PNG Salva come JPEG
Nome #
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 229
c-MYC oncoprotein dictates transcriptional profiles of ATP-binding cassette transporter genes in Chronic Myelogenous Leukemia CD34+ hematopoietic progenitor cells 228
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS 194
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 194
Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system. 192
Chondrogenic differentiation of human adipose mesenchimal stem cells: Influence of a biomimetic gelatin genipin crosslinked porous scaffold 190
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 190
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 189
Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model. 183
TERC and c-MYC COPY number gain in intraductal papillary mucinous neoplasms (IPMNs): promising biomarkers of progression to malignancy 178
Gelatin crosslinked with dehydroascorbic acid as a novel scaffold for tissue regeneration with simultaneous antitumor activity. 177
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression 173
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemia. 172
De-Regulation of Extracellular Matrix Proteins in Human Fibroblasts after Long-term and Low Concentrations of HEMA Exposition 166
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 166
TERC AND MYC COPY NUMBER GAIN AS POWERFUL GENETIC MARKERS FOR INTRADUCTAL PAPILLARY NEOPLASMS OF THE PANCREAS 164
A 41-Gene Signature Predicts Complete Response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) As Induction Therapy Prior to Autologous Stem-Cell Transplantation (ASCT) in Multiple Myeloma (MM) 163
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 160
State of the art biological therapies in pancreatic cancer 157
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 156
Cell adhesion and proliferation on gelatin-ascorbic acid scaffold 152
Matricellular protein expression as a new parameter to test in vitro cytotoxicity of a 3D biomimetic material 152
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 152
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS 150
Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide 150
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 150
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 148
Matricellular Protein Expression and Cell Ultrastructure as Parameters to Test In Vitro Cytotoxicity of a Biomimetic Scaffold 146
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 146
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 133
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 131
In vitro osteogenic and odontogenic differentiation of human dental pulp stem cells seeded on carboxymethyl cellulose-hydroxyapatite hybrid hydrogel 130
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients 126
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 123
Osteochondral tissue engineering strategies: the role of stem cell source 122
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 115
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME 113
Frontline Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Sequential Administration of Nilotinib 400 Mg Twice Daily and Imatinib 400 Mg Once Daily: a Phase 2 Multicentric Study 107
Overexpression of FBP1 is Associated to High Sokal Risk in Chronic Myeloid Leukemia Patients. 105
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307 101
Proteasome inhibitors: Bortezomib in multiple myeloma 75
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation 52
Totale 6.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021480 0 0 0 0 0 32 24 50 60 27 45 242
2021/2022837 60 34 28 58 75 69 9 37 37 140 130 160
2022/20231.073 91 178 48 147 69 77 27 60 178 28 77 93
2023/2024386 20 56 25 37 39 120 21 19 8 10 10 21
2024/2025923 42 120 68 77 157 58 57 50 8 94 35 157
2025/20261.030 163 137 209 111 304 106 0 0 0 0 0 0
Totale 6.400